CoraLite® Plus 488-conjugated ERK1/2 Monoclonal antibody

ERK1/2 Monoclonal Antibody for
Cat No. CL488-67170
Clone No.1A3D3

Host / Isotype

Mouse / IgG2a

Reactivity

Human, Mouse, Rat

Applications

ERK 1, ERK1, ERK1/2, ERT2, HS44KDAP, HUMKER1A, Insulin stimulated MAP2 kinase, MAP kinase 1, MAP kinase 3, MAP kinase isoform p44, MAPK 1, MAPK 3, MAPK3, p44 ERK1, p44 MAPK, P44ERK1, P44MAPK, PRKM3

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  {{ptg:cur_Conjugation}}
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

CL488-67170 targets ERK1/2 in applications and shows reactivity with Human, Mouse, Rat samples.

Tested Reactivity Human, Mouse, Rat
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen Peptide Predict reactive species
Full Name mitogen-activated protein kinase 3
Calculated Molecular Weight 38-43 kDa
Observed Molecular Weight 38-44 kDa
GenBank Accession NumberNM_002746
Gene Symbol ERK1
Gene ID (NCBI) 5595
Conjugate CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission Maxima Wavelengths488 nm / 515 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP27361
Storage Buffer PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

ERK1 and ERK2 belongs to the protein kinase superfamily. It is involved in both the initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors such as ELK-1. ERK1/2 catalized the reaction: ATP + a protein = ADP + a phosphoprotein. It is activated by tyrosine phosphorylation in response to INS and NGF. This antibody can recognize both ERK1 and ERK2 with the molecular mass of 38-44 kDa.

Protocols

Product Specific Protocols
FC protocol for CL Plus 488 ERK1/2 antibody CL488-67170Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...